Naturally, data should be protected from general release prior to either publication or authorization from the data submitters, whichever comes first. At a minimum, the journals should require valid accession numbers for microarray data as a requirement for publication, and these accession numbers should be included in the text of the manuscript to allow members of the community to find and access the underlying data.
Since its inception in 1999, the MGED Society has been working with the broader scientific community to establish standards for the exchange and annotation of microarray data. In December 2001, we proposed the MIAME guidelines (Brazma et al. 2001) and requested that interested parties provide feedback on its relevance and utility. The feedback from both researchers and scientific journals was overwhelmingly positive, yet almost everyone who responded also asked for help in implementing these guidelines.
Subsequently, in the summer of 2002, we submitted an open letter to various journals (e.g., Ball et al. 2002a Ball et al. , 2002b urging the community to adopt the MIAME requirements for microarray data publication. We provided a checklist so that authors could ensure that sufficient information would be available to allow their data to be re-analyzed by others. Again, the response from the community was extremely positive, and most of the major scientific journals now require publications describing microarray experiments to comply with the MIAME standards. While the adoption of these standards has greatly improved the accessibility of microarray data, much of these data remain on individual authors' websites in a variety of formats; consequently, obtaining and comparing data sets remains a significant challenge. Clearly we need additional requirements for publication that include submission of expression data to public data repositories.
Though one might ask why this requirement was not part of the original MIAME recommendation, the answer is quite simple-MIAME was ahead of its time. While the major public DNA sequence database groups at the NCBI and EMBL-EBI had developed nascent microarray data repositories, and work was under way to create a similar database at the DDBJ, submitting data to these databases was a considerable burden for authors. However, since that time, improvements in the data-entry utilities available for GEO (http://www.ncbi.nlm. nih.gov/geo), ArrayExpress (http://www. ebi.ac.uk/arrayexpress), and CIBEX (http://cibex.nig.ac.jp) databases, as well as a growing number of commercial and academic software packages capable of writing MAGE-ML documents (Spellman et al. 2002 ) that can be directly submitted to these public databases, have lowered the barriers for data submission to the point where we as a community must now reconsider that submission to one of these databases be a requirement.
Requiring authors to submit microarray data to the public databases will provide a number of distinct advantages to the entire research community: • These established repositories have a commitment to continued community service and to providing some level of assurance that published gene expression data sets will continue to be available into the future.
• Having the data available in these public repositories in a standardized format will not only make it more accessible, but it will allow expression data to be integrated with other relevant data, including the available genome sequences, single nucleotide polymorphism (SNP) and haplotype mapping information, the literature, and other resources that can aid in further interpretation of expression patterns. Although many authors now provide some or all of this information, the established databases are much more likely to ensure that these links are maintained and current.
• Curation of data submitted to public data repositories will assist authors, reviewers, and publishers in ensuring that the data comply with the MIAME requirements, further enhancing its utility.
• The standardization of microarray data formats will enable the development of additional data analysis and integration tools and makes it easier for scientists to access, query, and share data. • Finally, submission prior to publication will make it easier for referees to access the data confidentially, facilitating the review and publication process. In the same way that availability of sequence data had a profound impact on a wide range of disciplines, we believe that requiring that microarray data be deposited into public repositories as a necessity for publication will accelerate the rate of scientific discovery.
What this proposal requires is a change in the way in which we approach the publication of microarray-based studies. Both authors and journals have a responsibility to ensure that the requisite data are available, and because submitting MIAME-compliant data can take considerable time and effort, this process should be factored into review and publication timelines. However, while this process may be time consuming and painful at first, we believe that the benefits of building an open repository of microarray data will far outweigh any initial disadvantages. As always, it is our sincere hope that these suggestions stimulate discussion within the community and that together we can arrive at a consensus that ensures that microarray data are widely and easily accessible. Finally, we would like to urge the DDBJ, EMBL-EBI, and NCBI to work together toward exchanging all MIAME-compliant microarray data.
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